AASLD 2026
5 - 9 November 2026
FGF21 analogs in focus: From pathways to clinical evidence in MASH
Meeting description
Sunday, 08 November 2026
12:45 - 12:50
(MST)
Welcome & introduction
Arun Sanyal
12:50 - 13:00
(MST)
Unlocking FGF21: From biology to therapeutic potential
Arun Sanyal
13:00 - 13:15
(MST)
FGF21 analogs: Building the evidence base for a new approach to MASH
Kris Kowdley
13:15 - 13:25
(MST)
Audience Q&A
Arun Sanyal, Kris Kowdley
13:25 - 13:30
(MST)
Summary & close
Arun Sanyal
Keywords